Precision Biosciences (DTIL) Accumulated Depreciation & Amortization (2018 - 2025)

Precision Biosciences (DTIL) has 8 years of Accumulated Depreciation & Amortization data on file, last reported at $1.5 million in Q4 2025.

• Quarterly Accumulated Depreciation & Amortization fell 55.88% year-over-year to $1.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.5 million (down 55.88% YoY) and the FY2025 annual result came in at $1.5 million, down 55.88% from the prior year.
• Accumulated Depreciation & Amortization fell to $1.5 million in Q4 2025 per DTIL's latest filing, from $3.4 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $25.5 million in Q4 2023 and bottomed at $1.5 million in Q4 2025.
• The 5-year median for Accumulated Depreciation & Amortization is $21.9 million (2022), against an average of $15.2 million.
• The widest annual swing landed in 2021, when Accumulated Depreciation & Amortization increased 25.35%; it then sank 86.66% in 2024.
• Tracing DTIL's Accumulated Depreciation & Amortization over 5 years: stood at $23.9 million in 2021, then retreated by 8.55% to $21.9 million in 2022, then rose by 16.55% to $25.5 million in 2023, then slumped by 86.66% to $3.4 million in 2024, then plunged by 55.88% to $1.5 million in 2025.
• Per Business Quant, the three latest DTIL Accumulated Depreciation & Amortization figures stand at $1.5 million (Q4 2025), $3.4 million (Q4 2024), and $25.5 million (Q4 2023).

Peer Comparison